XLO

Xilio Therapeutics Inc

3.0852
0.1052 (3.53%)
Share Name Share Symbol Market Stock Type
Xilio Therapeutics Inc XLO NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.1052 3.53% 3.0852 10:00:00
Open Price Low Price High Price Close Price Previous Close
2.98 2.74 3.0852 3.0852 2.98
more quote information »

Recent News

Date Time Source Heading
26/5/202307:06EDGARCurrent Report Filing (8-k)
26/5/202307:01GLOBEXilio Therapeutics Announces Preliminary Clinical Data from..
09/5/202321:51EDGARQuarterly Report (10-q)
09/5/202321:46EDGARCurrent Report Filing (8-k)
09/5/202321:30GLOBEXilio Therapeutics Announces Pipeline and Business Updates..
26/4/202306:11EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
26/4/202306:06EDGARProxy Statement (definitive) (def 14a)
11/4/202306:58EDGARStatement of Ownership (sc 13g)
04/4/202306:12EDGARStatement of Changes in Beneficial Ownership (4)
04/4/202306:08EDGARInitial Statement of Beneficial Ownership (3)
04/4/202306:06EDGARCurrent Report Filing (8-k)
04/4/202306:05GLOBEXilio Therapeutics Announces Inducement Grant Under Nasdaq..
03/3/202309:03EDGARSecurities Registration: Employee Benefit Plan (s-8)
03/3/202308:05GLOBEXilio Therapeutics Announces Pipeline and Business Updates..
27/2/202323:30GLOBEXilio Therapeutics to Present at Upcoming Investor..
16/2/202323:30GLOBEXilio Therapeutics to Present at the Citi 2023 Virtual..
10/2/202300:16EDGARAmended Statement of Ownership (sc 13g/a)
02/2/202323:30GLOBEXilio Therapeutics to Present at the Guggenheim Healthcare..
26/1/202308:02EDGARStatement of Ownership (sc 13g)
10/1/202300:32EDGARCurrent Report Filing (8-k)
24/12/202208:31EDGARCurrent Report Filing (8-k)
23/11/202223:30GLOBEXilio Therapeutics to Host Live Virtual Program Spotlighting..
21/11/202222:03EDGARNotice of Effectiveness (effect)
17/11/202208:17EDGARInitial Statement of Beneficial Ownership (3)
10/11/202208:17EDGARSecurities Registration Statement (simplified Form) (s-3)
09/11/202223:51EDGARQuarterly Report (10-q)
09/11/202223:47EDGARCurrent Report Filing (8-k)
09/11/202223:30GLOBEXilio Therapeutics Announces Pipeline and Business Updates..
04/11/202222:30GLOBEXilio Therapeutics to Present at Cowen 6th Annual ‘IO Next’..
23/9/202206:05GLOBEXilio Therapeutics to Present at Guggenheim Nantucket..
17/9/202206:51EDGARInitial Statement of Beneficial Ownership (3)
17/9/202206:16EDGARStatement of Changes in Beneficial Ownership (4)
16/9/202206:16EDGARCurrent Report Filing (8-k)
16/9/202206:05GLOBEXilio Therapeutics Appoints Tomas J. Heyman to Board of..
07/9/202206:05GLOBEXilio Therapeutics to Present at Morgan Stanley 20th Annual..
09/8/202221:48EDGARQuarterly Report (10-q)
09/8/202221:37EDGARCurrent Report Filing (8-k)
09/8/202221:30GLOBEXilio Therapeutics Announces Encouraging Preliminary Phase 1..
24/6/202209:31EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
18/6/202206:32EDGARStatement of Changes in Beneficial Ownership (4)
18/6/202206:32EDGARStatement of Changes in Beneficial Ownership (4)
18/6/202206:32EDGARStatement of Changes in Beneficial Ownership (4)
18/6/202206:32EDGARStatement of Changes in Beneficial Ownership (4)
18/6/202206:07EDGARInitial Statement of Beneficial Ownership (3)
16/6/202221:30GLOBEXilio Therapeutics Announces Promotion of Martin Huber,..
14/6/202206:31EDGARCurrent Report Filing (8-k)
Your Recent History
NASDAQ
XLO
Xilio Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com

V: D: 20230606 06:33:22